EHAVE, Inc.
EHVVF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.48M
Close$
$-0.00
161.5% downside
Current Fair Value
161.5% downsideOvervalued by 161.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.48 Million |
|---|---|
| Enterprise Value | $2.57 Million |
| Earnings per Share | $0 |
| Beta | -0.19 |
| Outstanding Shares | 1,263,043,879 |
Return
| Return on Equity | 80.25% |
|---|---|
| Return on Assets | -154.48% |
| Return on Invested Capital | 84.43% |
Valuation & Multiples
| P/E Ratio | -1.25 |
|---|---|
| PEG | 6.5 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 1174.6 |
| Enterprise Value to EBIT | -0.32 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.73 |
| Debt to Equity | -0.26 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About EHAVE, Inc.
1 employees
CEO: Benjamin Kaplan
Established in 2011 and headquartered in Miami, Florida, EHAVE, Inc. is a healthcare company concentrating on the development of medical psychedelics and an integrated mental health data platform. This platform is designed to work with b...